Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal

@article{Coffin2013CostEffectivenessOD,
  title={Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal},
  author={Phillip Oliver Coffin and Sean D. Sullivan},
  journal={Annals of Internal Medicine},
  year={2013},
  volume={158},
  pages={1 - 9}
}
BACKGROUND Opioid overdose is a leading cause of accidental death in the United States. OBJECTIVE To estimate the cost-effectiveness of distributing naloxone, an opioid antagonist, to heroin users for use at witnessed overdoses. DESIGN Integrated Markov and decision analytic model using deterministic and probabilistic analyses and incorporating recurrent overdoses and a secondary analysis assuming heroin users are a net cost to society. DATA SOURCES Published literature calibrated to… 

Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities

TLDR
Naloxone distribution to heroin users for lay overdose reversal is highly likely to reduce overdose deaths in target communities and is robustly cost-effective, even within the constraints of this conservative model.

Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.

Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users.

The cost and impact of distributing naloxone to people who are prescribed opioids to prevent opioid-related deaths: findings from a modelling study.

TLDR
In Australia, scaling-up take-home naloxone by 2030 to reach 90% of people prescribed daily doses of ≥ 50 mg of oral morphine equivalents would be cost-effective and save more than 650 lives.

Economic impact of a novel naloxone autoinjector on third-party payers.

TLDR
A deterministic model demonstrated that NAI acquisition costs can be offset through medical cost reductions with improved timely access to naloxone.

Costs of opioid overdose education and naloxone distribution in New York City.

TLDR
Funders should consider that providing free naloxone to OEND programs does not cover full operating costs, and further exploration of cost-effectiveness and program efficiency should be considered across different types of OEND settings.
...

References

SHOWING 1-10 OF 75 REFERENCES

Prescription naloxone: a novel approach to heroin overdose prevention.

Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose?

TLDR
A trial could be conducted to determine whether this intervention improves the management of overdose or results in a net increase in harm (by undermining existing prevention strategies, precipitating naloxone related complications, or resulting in riskier heroin use).

Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco

TLDR
Findings from the DOPE Project add to a growing body of research that suggests that IDUs at high risk of witnessing overdose events are willing to be trained on overdose response strategies and use take-home naloxone during overdose events to prevent deaths.

Community-based opioid overdose prevention programs providing naloxone - United States, 2010.

TLDR
Providing opioid overdose education and naloxone to persons who use drugs and to people who might be present at an opioid overdose can help reduce opioid overdose mortality, a rapidly growing public health concern.

Opioid overdose prevention and naloxone distribution in Rhode Island.

TLDR
An overview and pilot evaluation of PONI (Preventing Overdose and Naloxone Intervention), the opioid overdose prevention program in Rhode Island is presented.

Evaluation of a Naloxone Distribution and Administration Program in New York City

TLDR
Naloxone administration by IDUs is feasible as part of a comprehensive overdose prevention strategy and may be a practicable way to reduce overdose deaths on a larger scale.

Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport.

TLDR
Giving naloxone to patients with heroin overdoses in the field and then allowing them to sign out AMA resulted in no identifiable deaths within this study population.

Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings

TLDR
The present study describes the frequency of drug overdose and the factors related to overdose among heroin users recruited in non-clinical settings as part of a study of early and episodic heroin users.

HIV transmission and the cost-effectiveness of methadone maintenance.

TLDR
This study determined the cost-effectiveness of expanding methadone maintenance treatment for heroin addiction, particularly its effect on the HIV epidemic, on the basis of commonly accepted criteria for medical interventions.
...